Renal function after autologous bone marrow transplantation in children:: a long-term prospective study

被引:73
作者
Frisk, P
Bratteby, LE
Carlson, K
Lönnerholm, G
机构
[1] Univ Uppsala Hosp, Dept Med, Uppsala, Sweden
[2] Univ Uppsala Hosp, Dept Clin Physiol, Uppsala, Sweden
[3] Uppsala Univ, Childrens Hosp, Uppsala, Sweden
关键词
renal function; autologous; bone marrow transplantation; children; long-term follow-up;
D O I
10.1038/sj.bmt.1703312
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
We measured glomerular filtration rate (GFR), effective renal plasma flow (ERPF) and the concentrating capacity of the kidneys in children after autologous BMT. Twenty-six patients had received TBI in their conditioning regimen and 14 patients had received chemotherapy only. Median follow-up was 10 years. Mean GFR before BMT was close to normal in both groups. Mean GFR decreased from 124 [CI 114,134] ml/min/1.73 m(2) before BMT to 99 [CI 82,115] ml/min/1.73 m(2) 6 months after BMT in the + TBI group (P < 0.001). There was no significant change in the -TBI group. Mean ERPF before BMT was high: 1110 [95% CI 830,1390] ml/min/i.73 m(2) in the + TBI group and 910 [CI 570,1250] ml/min/1.73 m(2) in the - TBI group. Six months after BMT, there was a tendency to a decrease in ERPF in the +TBI group, to 760 [CI 580,9401 ml/min/1.73 m(2) (P=0.064). After this initial decrease, GFR and ERPF remained essentially unchanged in both groups. The mean concentrating capacity of the kidneys was normal before and after BMT. In seven patients chronic renal impairment developed after BMT (GFR <70 ml/min/1.73 m(2)). All had received TBI. They had also received more nephrotoxic antibiotics than the other patients. We conclude that TBI was the principal cause of deterioration of renal function after BMT, possibly by limiting compensatory hyperperfusion and resulting in a fall in GFR. Antibiotic treatment may have contributed.
引用
收藏
页码:129 / 136
页数:8
相关论文
共 38 条
[1]   DELAYED RENAL-FAILURE WITH EXTENSIVE MESANGIOLYSIS FOLLOWING BONE-MARROW TRANSPLANTATION [J].
ANTIGNAC, C ;
GUBLER, MC ;
LEVERGER, G ;
BROYER, M ;
HABIB, R ;
LACOSTE, M ;
BEZIAU, A ;
NAIZOT, C .
KIDNEY INTERNATIONAL, 1989, 35 (06) :1336-1344
[2]  
BERG U, 1989, TRANSPLANT P, V21, P3092
[3]   RADIATION NEPHRITIS FOLLOWING TOTAL-BODY IRRADIATION AND CYCLOPHOSPHAMIDE IN PREPARATION FOR BONE-MARROW TRANSPLANTATION [J].
BERGSTEIN, J ;
ANDREOLI, SP ;
PROVISOR, AJ ;
YUM, M .
TRANSPLANTATION, 1986, 41 (01) :63-66
[4]  
Berns JS, 1997, SEMIN NEPHROL, V17, P54
[5]  
CANNELL PK, 1992, BONE MARROW TRANSPL, V10, P337
[6]   CLINICAL COURSE OF LATE-ONSET BONE-MARROW TRANSPLANT NEPHROPATHY [J].
COHEN, EP ;
LAWTON, CA ;
MOULDER, JE ;
BECKER, CG ;
ASH, RC .
NEPHRON, 1993, 64 (04) :626-635
[7]   BONE-MARROW TRANSPLANT NEPHROPATHY - RADIATION NEPHRITIS REVISITED [J].
COHEN, EP ;
LAWTON, CA ;
MOULDER, JE .
NEPHRON, 1995, 70 (02) :217-222
[8]   CHRONIC CYCLOSPORINE-ASSOCIATED NEPHROTOXICITY IN BONE-MARROW TRANSPLANT PATIENTS [J].
DIETERLE, A ;
GRATWOHL, A ;
NIZZE, H ;
HUSER, B ;
MIHATSCH, MJ ;
THIEL, G ;
TICHELLI, A ;
SIGNER, E ;
NISSEN, C ;
SPECK, B .
TRANSPLANTATION, 1990, 49 (06) :1093-1100
[9]   ACUTE-RENAL-FAILURE IN PATIENTS FOLLOWING BONE-MARROW TRANSPLANTATION - PREVALENCE, RISK-FACTORS AND OUTCOME [J].
GRUSS, E ;
BERNIS, C ;
TOMAS, JF ;
GARCIACANTON, C ;
FIGUERA, A ;
MOTELLON, JL ;
PARAISO, V ;
TRAVER, JA ;
FERNANDEZRANADA, JM .
AMERICAN JOURNAL OF NEPHROLOGY, 1995, 15 (06) :473-479
[10]  
GUINAN EC, 1988, BLOOD, V72, P451